NDC 51672-2131-01 - Childrens Loratadine Sugar Free
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2131
- Requested NDC
- 51672-2131-01
- Package NDCs from labels
- 51672-2131-4, 51672-2131-8, 51672-2131-1, 51672-2131-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-08-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Childrens Loratadine Oral Solution Sugar Free | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-08-30 | HUMAN OTC DRUG LABEL |
| Childrens Loratadine Oral Solution Sugar Free | Preferred Pharmaceuticals Inc. | 2026-01-15 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2131-1 | Childrens LoratadineSugar Free | 1 in 1 CARTON | SOLUTION | 1 | 4 | |
| 51672-2131-1 | Childrens LoratadineSugar Free | 240 mL in 1 BOTTLE | SOLUTION | 240 | 4 | |
| 51672-2131-4 | Childrens LoratadineSugar Free | 60 mL in 1 BOTTLE | SOLUTION | 60 | 4 | |
| 51672-2131-4 | Childrens LoratadineSugar Free | 1 in 1 CARTON | SOLUTION | 1 | 4 | |
| 51672-2131-8 | Childrens LoratadineSugar Free | 120 mL in 1 BOTTLE | SOLUTION | 120 | 4 | |
| 51672-2131-8 | Childrens LoratadineSugar Free | 1 in 1 CARTON | SOLUTION | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2131 | CHILDRENS LORATADINE SUGAR FREE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 3 | Current NDC, Legacy NDC, 6 package rows | 20230805_58eaab62-ac36-4080-8ded-9b472dddc617.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2131-8 | ML - Milliliter | 51672-2131 | 3ff51a3e-245f-4e75-a21e-7fe62e546dfd | 1 | 2018-02-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BACTERIOSTATIC WATER | BACTERIOSTATIC WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b0ef9b-600a-40dc-e053-2a95a90aa07e | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b1cb12-0b2d-0c0f-e053-2a95a90ac3b6 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| LORATADINE | LORATADINE | AMZ789 LLC | db71197e-d633-644d-e053-2a95a90a261d | 2025-01-08 | Warnings | 7AJO3BO7QN |
| Emetrol Children Mixed Berry | PHOSPHORATED CARBOHYDRATE | WellSpring Pharmaceutical Corporation | ecff699b-d4d8-4407-8119-3e9a1100024a | 2025-01-08 | Warnings | E4GA8884NN |
| Chemtox | TRITICUM AESTIVUM, BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, RHAMNUS PURSHIANA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), THYROIDINUM (SUIS), BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, | BioActive Nutritional, Inc. | a480e5f4-5f9e-4b23-b257-b0ac1ebfc115 | 2025-01-07 | Warnings | E4GA8884NN 506T60A25R |
| Prevention Oncology Mouth Rinse | GLYCERIN | Prevention Health Sciences, Inc. | 1ec9ed1c-bcb6-3a0a-e054-00144ff8d46c | 2025-01-01 | Warnings | PDC6A3C0OX |
| VISTA MEIBO TEARS Propylene Glycol 0.6% w/v Advanced Dry Eye Relief Lubricating Drops 10 ml | PROPYLENE GLYCOL | Red Wedding LLC | b2c2fd0f-b944-6b0b-e053-2995a90aa216 | 2025-01-01 | Warnings | 6DC9Q167V3 |
| CLENZIDERM THERAPEUTIC MOISTURIZER | GLYCERIN | Obagi Cosmeceuticals LLC | d60e22e3-831e-4787-a82c-e7763c287553 | 2025-01-01 | Warnings | PDC6A3C0OX |
| LORATADINE | LORATADINE | CVS PHARMACY, INC | 4e74e322-7f6e-467c-96c0-9b531ddb429b | 2024-12-31 | Warnings | 7AJO3BO7QN |
| Claritin | LORATADINE TABLET | Lil' Drug Store Products, Inc. | f0e77162-c601-1a0f-e053-2a95a90ab714 | 2024-12-31 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | Advanced Rx Pharmacy of Tennessee, LLC | 01cb43cf-57a9-f189-e063-6294a90afd88 | 2024-12-31 | Warnings | 7AJO3BO7QN |
| Rite Aid Hydration Lubricant Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Rite Aid Corporation | ecac1351-e944-21da-e053-2995a90a6d34 | 2024-12-31 | Warnings | 6DC9Q167V3 |
| CHILDRENS LORATADINE | LORATADINE | SAFEWAY | dad93ac1-ae0b-4918-8c62-92107e79a4b2 | 2024-12-29 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | WALGREEN COMPANY | 645c26ab-08ab-4a69-ae7d-7802d8ec5922 | 2024-12-29 | Warnings | 7AJO3BO7QN |
| Wal-itin | LORATADINE | Walgreens | 176fe4f5-f72d-4fc2-bd9a-20626c9ab634 | 2024-12-27 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | Premier Value | dc22862e-fe91-4900-8c2b-1ca45aeedbf0 | 2024-12-27 | Warnings | 7AJO3BO7QN |
| CHILDRENS LORATADINE | LORATADINE | TARGET CORPORATION | c02ad905-2363-4092-a90e-3be789112cb1 | 2024-12-27 | Warnings | 7AJO3BO7QN |
| Childrens Allergy | LORATADINE | TARGET CORPORATION | 9507c223-ea75-477e-b765-f5d0bcba5ff9 | 2024-12-27 | Warnings | 7AJO3BO7QN |
| Allervarx | LORATADINE | Innovus Pharmaceuticals, Inc. | ec4d1e77-6995-4228-8e63-a9ab6232dace | 2024-12-27 | Warnings | 7AJO3BO7QN |
| Allervarx | LORATADINE | Innovus Pharmaceuticals, Inc. | 885e81ae-5ea3-4d14-8666-8c2698767014 | 2024-12-27 | Warnings | 7AJO3BO7QN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.